← back to search

Vesna Grivcheva‐Panovska

Ss. Cyril and Methodius University in Skopje ·
Area of research
Genetics · Hematology
Research interest
Research interests include Coagulation, Bradykinin, Polyphosphates, and Angioedema, Hemophilia Treatment and Research, Complement system in diseases, and Urticaria and Related Conditions.
h-index
14
citations
1,072
works
43
NIH funding
primary concept
email

Recent publications

Unmet needs in hereditary angioedema: an international survey of physicians
Orphanet Journal of Rare Diseases 2025cited by 8position: middledoi
Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitor
Journal of Allergy and Clinical Immunology Global 2025cited by 7position: middledoi
Long-Term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label Extension
The Journal of Allergy and Clinical Immunology In Practice 2025cited by 3position: middledoi
Sebetralstat for On‐Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT‐S
Clinical and Translational Allergy 2025cited by 1position: middledoi
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks
New England Journal of Medicine 2024cited by 56position: middledoi
Hereditary Angioedema Attacks in Patients Receiving Long-Term Prophylaxis: A Systematic Review
Clinical Reviews in Allergy & Immunology 2024cited by 19position: middledoi
The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation
Clinical & Experimental Allergy 2024cited by 5position: middledoi
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial
The Lancet 2023cited by 47position: middledoi
International Consensus on the Use of Genetics in the Management of Hereditary Angioedema
The Journal of Allergy and Clinical Immunology In Practice 2019cited by 78position: middledoi
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema
New England Journal of Medicine 2018cited by 113position: middledoi
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial
The Lancet 2017cited by 64position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mauro Cancian · Bambino Gesù Children's Hospital2 papers (2024–2025)Marcin Stobiecki · Jagiellonian University2 papers (2024–2025)Christopher Yea · KalVista Pharmaceuticals (United States)2 papers (2024–2025) · 1 papers (2017–2017) · 1 papers (2017–2017)Petra Staubach · Johannes Gutenberg University Mainz1 papers (2025–2025)Raffi Tachdjian · University of California, Los Angeles1 papers (2024–2024)Laurence Bouillet · Wake Forest University1 papers (2024–2024)Marc A. Riedl · La Jolla Institute for Immunology1 papers (2017–2017)Shmuel Kivity · Johannes Gutenberg University Mainz1 papers (2017–2017) · 1 papers (2017–2017) · 1 papers (2024–2024)Danny M. Cohn · Amsterdam University of Applied Sciences1 papers (2025–2025)Timothy Craig · Johannes Gutenberg University Mainz1 papers (2025–2025)Isaac Melamed · IMMUNOe Research Center1 papers (2025–2025)Paul Audhya · Framingham State University1 papers (2024–2024)James Baker · Johannes Gutenberg University Mainz1 papers (2017–2017)Andrea Zanichelli · University of Milan1 papers (2025–2025)Marco Cicardi · University of Milan1 papers (2017–2017)Henriette Farkas · Semmelweis University1 papers (2025–2025)